中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

140 records (took 0.019 seconds)

    Complex query handling
    1.
    发明授权
    Complex query handling 有权
    复杂的查询处理

    公开(公告)号：US09323828B2

    公开(公告)日：2016-04-26

    申请号：US13104699

    申请日：2011-05-10

    Applicant: Ian Mark Shore ,  Samuel Jonathan Smith ,  Martin James Smithson

    Inventor： Timothy Peter Griffith ,  Ian Mark Shore ,  Samuel Jonathan Smith ,  Martin James Smithson

    IPC: G06F7/00 ,  G06F17/30

    CPC classification number: G06F17/3064 ,  G06F17/30696

    Abstract: Processing a query for a database includes: receiving a portion of a query from a client device in a server implemented by at least one processor, the portion of the query comprising an incomplete component; determining that the incomplete component is one of multiple predefined types with the server; providing the incomplete component to an auto-complete function specific to the determined type of the incomplete component; receiving in the server a suggestion for completing the query from the auto-complete function, the suggestion being specific to the type of the incomplete component; and providing the suggestion from the server to the client device.

    Abstract translation: 处理对数据库的查询包括：从由至少一个处理器实现的服务器中的客户端设备接收查询的一部分，所述查询的部分包括不完整的组件; 确定不完整组件是服务器的多种预定义类型之一; 将不完整组件提供给所确定类型的不完整组件特有的自动完成功能; 在服务器中接收完成自动完成功能查询的建议，该建议与不完整组件的类型有关; 并从服务器向客户端设备提供建议。

    RISK MARKERS FOR CARDIOVASCULAR DISEASE
    6.
    发明申请
    RISK MARKERS FOR CARDIOVASCULAR DISEASE 有权
    心血管疾病危险标志

    公开(公告)号：US20130177551A1

    公开(公告)日：2013-07-11

    申请号：US13683527

    申请日：2012-11-21

    Applicant: Stanley L. Hazen ,  Michael Kinter ,  Marc S. Penn ,  Jonathan Smith ,  Lemin Zheng

    Inventor： Stanley L. Hazen ,  Michael Kinter ,  Marc S. Penn ,  Jonathan Smith ,  Lemin Zheng

    IPC: G01N33/92

    CPC classification number: G01N33/561 ,  C07K16/18 ,  G01N33/6893 ,  G01N33/92 ,  G01N2333/775 ,  G01N2800/32

    Abstract: Provided herein methods for determining whether a subject, particularly a human subject, is at risk of developing, having, or experiencing a complication of cardiovascular disease, and methods of treating subjects who are identified by the current methods of being at risk for cardiovascular disease. In one embodiment, the method comprises determining levels of one or more oxidized apolipoprotien A-I related biomolecules in a bodily sample from the subject. Also, provided are kits and reagents for use in the present methods. Also provided are methods for monitoring the status of cardiovascular disease in a subject or the effects of therapeutic agents on subjects with cardiovascular disease. Such method comprising determining levels of one or more oxidized apolipoprotein A-I related molecules in bodily samples taken from the subject over time or before and after therapy.

    Abstract translation: 本文提供用于确定受试者，特别是人类受试者是否处于发展，具有或经历心血管疾病并发症的风险的方法，以及治疗由目前的心血管疾病风险的方法鉴定的受试者的方法。 在一个实施方案中，该方法包括确定来自受试者的身体样品中一种或多种氧化的载脂蛋白A-I相关生物分子的水平。 此外，提供了用于本方法的试剂盒和试剂。 还提供了用于监测受试者心血管疾病状态或治疗剂对心血管疾病受试者的影响的方法。 这种方法包括测定在受试者随时间或治疗之前或之后取自受试者的身体样品中一种或多种氧化的载脂蛋白A-1相关分子的水平。

Patent Agency Ranking